Urgent

Breathlessness in palliative / advanced disease (malignant & non-malignant dyspnoea; chronic refractory breathlessness)

Palliative / symptom control · Geriatric & General
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Management of distressing breathlessness in advanced cancer, end-stage cardiorespiratory disease and the dying patient, where breathlessness persists despite optimal treatment of reversible causes (chronic refractory breathlessness). Combines treatment of reversible contributors, non-pharmacological measures (which are first-line and effective), low-dose opioids to reduce the sensation of breathlessness, and anxiolytics for the associated anxiety. Oxygen helps only if the patient is hypoxaemic.

Red flags

  • Acute reversible emergency: tension/large pneumothorax, massive PE, SVC obstruction with stridor/facial swelling, upper airway obstruction, acute pulmonary oedema
  • Rapidly worsening hypoxia/respiratory distress in a patient who would want active treatment
  • Stridor / impending airway obstruction
  • Massive haemoptysis (crisis plan: opioid + midazolam, dark towels, stay with patient)

Assessment

Differential diagnosis

  • Reversible contributors to treat: anaemia, pleural effusion, pericardial effusion, infection, bronchospasm, pulmonary embolism, heart failure, SVC obstruction, lymphangitis, airway obstruction, ascites splinting diaphragm
  • Underlying: advanced cancer/lymphangitis carcinomatosa, COPD, ILD, heart failure, end-stage neuromuscular disease
  • Anxiety/panic amplifying breathlessness (breathing-thinking-functioning cycle)

Investigations

  • Assess severity and impact (e.g. numerical/modified Borg scale), and whether in last days of life (limits investigation)
  • Identify treatable causes proportionate to stage: SpO2, FBC (anaemia), CXR/US (effusion), consider PE, BNP/echo (heart failure)
  • Review drugs and fluid status; assess anxiety component
  • In the actively dying, minimise investigations and focus on comfort

Management

  • Treat reversible causes where appropriate to goals: drain symptomatic effusion, transfuse if symptomatic anaemia, bronchodilators/steroids for bronchospasm/lymphangitis, diuretics for heart failure, treat infection, dexamethasone + stent for SVC obstruction
  • Non-pharmacological FIRST-LINE: handheld fan to the face (trigeminal cooling), positioning, breathing control/pacing techniques, reassurance, cool airflow, pulmonary rehab concepts, managing the breathing-thinking-functioning cycle
  • Low-dose opioid to reduce breathlessness sensation: oral/SC morphine (opioid-naive, start low); titrate; this is the key pharmacological step and is safe at low dose
  • Anxiolytic for associated anxiety/panic or in the last days: low-dose benzodiazepine (lorazepam sublingual PRN, or midazolam SC/CSCI if dying)
  • Oxygen ONLY if hypoxaemic (SpO2 low) — a fan is as effective as oxygen in the non-hypoxaemic breathless patient
  • In last days of life: morphine +/- midazolam via PRN SC and/or syringe driver; add antisecretory for rattle
  • Review and titrate regularly; involve specialist palliative care for refractory breathlessness

Drugs & doses

Immediate-release oral morphine 1-2.5 mg PO (opioid-naive) up to 4-hourly and PRN, titrate; or morphine 1-2.5 mg SC PRN; if already on opioid, increase background by ~25-50% [verify local dose]
Modified-release low-dose morphine (e.g. 5 mg PO twice daily) once requirement established for chronic refractory breathlessness [verify local dose]
Lorazepam 0.5 mg sublingual PRN for episodic breathlessness/panic (max ~2 mg/day) [verify local dose]
Midazolam 2.5-5 mg SC PRN / 10 mg/24 h CSCI for breathlessness-related distress in the last days of life [verify local dose]
Dexamethasone 4-8 mg PO/SC once daily for lymphangitis carcinomatosa, SVC obstruction, airway tumour, bronchospasm (give early in day) [verify local dose]
Oxygen titrated ONLY if SpO2 low/hypoxaemic (not routinely for breathlessness without hypoxaemia) [verify local]
Nebulised saline / bronchodilator (salbutamol 2.5-5 mg neb) if bronchospasm or tenacious secretions [verify local dose]

Disposition

Manage in preferred place of care with community/specialist palliative support; admit only if a reversible cause needs inpatient treatment and that fits the patient's goals.

Complications & pitfalls

  • Panic/anxiety escalation (breathing-thinking-functioning cycle)
  • Opioid/benzodiazepine over-sedation if over-titrated (start low in opioid-naive/frail)
  • Missed reversible cause (effusion, PE, anaemia, SVC obstruction)
  • Social isolation and distress for patient and family

Exam pearls

  • A handheld fan directed at the face is a genuinely effective, evidence-based first-line measure — as good as oxygen when the patient is not hypoxaemic.
  • Low-dose opioids reduce the sensation of breathlessness and are safe — do not withhold through fear of respiratory depression.
  • Oxygen only helps the hypoxaemic patient; do not use it reflexively for breathlessness.
  • Treat the anxiety component — breathlessness and panic amplify each other.
  • Guidance: NICE NG31 (last days of life), Scottish Palliative Care Guidelines, Palliative Care Formulary; MND/COPD/heart-failure breathlessness pathways.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.